AKT1E17K -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363.
John P, Waldt N, Liebich J, Kesseler C, Schnabel S, Angenstein F, Sandalcioglu IE, Scherlach C, Sahm F, Kirches E, Mawrin C.
John P, et al. Among authors: liebich j.
Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12780. doi: 10.1111/nan.12780. Epub 2021 Dec 30.
Neuropathol Appl Neurobiol. 2022.
PMID: 34837233